Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.62 USD | +0.08% | -0.24% | +3.95% |
Apr. 30 | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
Apr. 25 | H.C. Wainwright Adjusts Price Target on Evotec to $11 From $14, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+3.95% | 0 | |
+3.84% | 12.7B | |
+12.72% | 9.46B | |
+9.73% | 5.67B | |
-2.85% | 5.44B | |
+8.25% | 5.31B | |
+13.99% | 4.49B | |
+16.48% | 4.46B | |
+1.85% | 4.07B | |
+5.44% | 3.92B |
- Stock Market
- Equities
- EVO Stock
- News Eaton Vance Ohio Municipal Income Trust
- Morgan Stanley Upgrades Evotec to Overweight From Equal Weight, Adjusts Price Target to $16 From $12